Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Risk Assessment

View and export this data going back to 1997. Start your Free Trial

What is Tonghua Golden-horse Pharmaceutical Industry Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Tonghua Golden-horse Pharmaceutical Industry Co is: High Risk: High uncertainty with risk-return tradeoff.

Competitive Comparison of Tonghua Golden-horse Pharmaceutical Industry Co's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, Tonghua Golden-horse Pharmaceutical Industry Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tonghua Golden-horse Pharmaceutical Industry Co's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tonghua Golden-horse Pharmaceutical Industry Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Tonghua Golden-horse Pharmaceutical Industry Co's Risk Assessment falls into.

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Tonghua Golden-horse Pharmaceutical Industry Co Risk Assessment Related Terms

Thank you for viewing the detailed overview of Tonghua Golden-horse Pharmaceutical Industry Co's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766) » Definitions » Risk Assessment

Traded in Other Exchanges

N/A

Address

No. 999, Jinma Road, Erdaojiang District, Tonghua, Jilin, CHN, 134001

Website

http://www.thjm.cn

Tonghua Golden-horse Pharmaceutical Industry Co Ltd is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutical products. It is a comprehensive pharmaceutical company integrating the production, sales, and research and development of pharmaceuticals. Tonghua's products mainly focus on rheumatism, bone diseases, digestion, tumors, and gynecology and distributing it mainly in the eastern part of China.

Executives

Wei Ying Jie	Director
Zan Bao Shi	Director
Wu Cheng Yu	Directors, executives
Zhang De Ju	Supervisors
Li Ju	Supervisors
Feng Ran	Director

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Headlines

No Headlines